|
Net
loss per share is computed using the weighted average number of shares of Common Stock outstanding less the number of shares subject
to repurchase.
The
following table sets forth the computation of basic and diluted net loss per share for the periods indicated (in thousands, except share
data):
| Schedule of basic and diluted net loss per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three Months Ended June 30,
|
|
|
Six Months Ended June 30,
|
|
| |
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
| Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
$ |
(21,017 |
) |
|
$ |
(10,418 |
) |
|
$ |
(50,755 |
) |
|
$ |
(23,967 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Denominator - basic and diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average common shares outstanding |
|
|
72,335,952 |
|
|
|
59,714,562 |
|
|
|
72,335,952 |
|
|
|
59,713,471 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss per share - basic and diluted |
|
$ |
(0.29 |
) |
|
$ |
(0.17 |
) |
|
$ |
(0.70 |
) |
|
$ |
(0.40 |
) |
The
following table sets forth the amounts excluded from the computation of diluted net loss per share as of June 30, 2022 and 2021 because
their effect was anti-dilutive.
| Schedule of anti-dilutive net loss per share |
|
|
|
|
|
|
|
|
| |
|
June 30, |
|
| |
|
2022 |
|
|
2021 |
|
| Stock options outstanding |
|
|
7,983,614 |
|
|
|
1,018,125 |
|
| Non-vested shares of restricted stock |
|
|
6,759,150 |
|
|
|
72,989 |
|
| Warrants (a)
|
|
|
- |
|
|
|
- |
|
| Convertible notes (a)
|
|
|
- |
|
|
|
- |
|
| |
(a) |
The Convertible Notes and
warrants referred to in Notes 10 and 13 were also excluded on an as converted basis because their effect would have been anti-dilutive. |
|